Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus - Wikidata - wikimedia - TriplyDB

Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus

Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus

http://www.wikidata.org/entity/Q34494943

about

Nonsteroidal anti-inflammatory drugs may reduce enterohepatic recirculation of mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases.Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus Paediatric use of mycophenolate mofetil.Biomarkers and updates on pediatrics lupus nephritis.Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?Impact of glomerular kidney diseases on the clearance of drugs.Optimization of pediatric rheumatology therapeutics.Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Pharmacokinetic modeling of therapies for systemic lupus erythematosus.Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis.Mycophenolic Acid Pharmacokinetics and Relapse in Children with Steroid-Dependent Idiopathic Nephrotic Syndrome.Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus.Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil.Pharmacokinetic Variability of Mycophenolic Acid in Pediatric and Adult Patients With Hematopoietic Stem Cell Transplantation.

P2860

Q33874609-D1C9C354-2975-4E38-BB97-2652E8625591 Q34554467-4ED829A9-26C9-4209-BD90-0EC79448E919 Q34635584-60DFF2FB-3F55-48D5-A590-C1B5FFDAEBF8 Q36111207-636967A8-9060-4F54-BB28-EA4491D3DFE6 Q36243640-A2140885-214D-4F06-82E7-5CCE03255B5A Q36278355-E6285C9B-71C0-4397-A066-5B6CF25FC74B Q36562448-8818B241-DB1E-4F2E-93DB-1714B10B8C25 Q37167062-4A3045B5-5139-4541-9538-4FC46782370A Q37956717-D82A791C-C39E-441A-9422-2E0399BED892 Q37974647-5F873A2D-A05F-4247-92D9-0B260B3F4176 Q37991520-21C68334-8872-49D8-A5A8-837F78527181 Q38087925-ABD52085-B655-45DD-BCCA-5D39E129118F Q38170321-35AEB1A0-AB92-40E5-8B10-80855D9B4A23 Q38542910-F5A02BE9-E7AD-4E17-9686-27028D632DF9 Q38768108-9A685056-8068-47EE-AF37-5F2593DDABB4 Q39573394-BB2ACA5D-43C2-47E6-A887-B558B56B7FB5 Q42360715-15669C09-894F-423B-8A4F-F3CAF5F5DDDD Q45353017-15E4C284-5429-4D98-82D1-ED5CD8E7D0A0 Q53126891-302EF7E5-7677-4BEF-834F-FF217B14DC2F

P2860

Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus

http://www.wikidata.org/entity/Q34494943

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@ast

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@en

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@nl

type

label

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@ast

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@en

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@nl

prefLabel

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@ast

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@en

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@nl

P1433

Q34494943-7C8161D6-8635-450E-88A2-A0120F5DF787

P1476

Q34494943-F03E4237-CAE3-4B33-BFD9-2C214ACD0588

P2093

Q34494943-187878E3-9B04-4F93-9938-0F90F2BB768C

Q34494943-3204EA08-4328-4568-9BA6-2FC8D11EEC4A

Q34494943-428169F2-CC79-4864-BA7A-FE625082A1E2

Q34494943-4E6BB54E-E2FF-4492-9142-DDF109C394A1

Q34494943-685C5D7E-2BDF-4156-8DA0-9456717DDD16

Q34494943-7075F0A2-5CAE-4B7A-A22A-5F411B6A1647

Q34494943-97D525DE-FE5B-4007-891F-19ECCB91EDCF

Q34494943-E9BECC17-5D61-4181-B009-94D147B703F8

Q34494943-F1716BDB-8A8B-4B4A-8049-71212735E038

Q34494943-FD3C846D-5597-498D-9D7F-7BB326284CDA

P2860

Q34494943-05D859F5-8E89-45AB-ACC1-E88A00049125

Q34494943-107F0EE7-B65D-4B96-B70C-A131DF8A5604

Q34494943-2A117694-D87E-43CC-84DA-885B60364785

Q34494943-2C50FB49-B00A-4AA7-9CEA-1EDA67A1340F

Q34494943-3D1B6AC8-E113-433E-BAD2-93BB7A3D2EAD

Q34494943-4617621A-2702-4B8C-A768-6B75BDC6D54F

Q34494943-49811910-1F6F-4F01-9908-237407E09AD4

Q34494943-4C2C89FF-63AB-47BA-BE50-C0583CE1D20B

Q34494943-500CBB48-4DE3-408B-AADF-54BFC138FE07

Q34494943-53DDE512-EFCA-4123-A70B-8A9E3B832090

P304

Q34494943-CFEED825-FB6F-4E00-941A-DF42903596A2

P31

Q34494943-A92757D5-6EE5-4616-BAD9-20237A635910

P356

Q34494943-4F425F44-8C4B-4A79-8499-91F632F88594

P433

Q34494943-C79CB1C0-0008-4083-ACDF-45FF5F0C75ED

P478

Q34494943-93579FD4-C2B5-4B3B-9E83-399517EB5621

P577

Q34494943-8A2A6567-CDE8-47BA-AFDA-557C0D3BDD67

P5875

Q34494943-D91EED0A-E0F8-4A11-BD98-08B86C5B985C

P698

Q34494943-C055FD51-693D-456D-8A6A-DB16BF8E4DC9

P932

Q34494943-B8A1DD46-A32E-4696-908A-E8D6C8EC1E96

P356

J.SEMARTHRIT.2010.05.007

P1433

Seminars in Arthritis and Rheumatism

P1476

Pharmacokinetics and pharmacod ...... t systemic lupus erythematosus

@en

P2093

Alexander A Vinks

http://www.w3.org/2001/XMLSchema#string

Anna Carmela P Sagcal-Gironella

http://www.w3.org/2001/XMLSchema#string

Blair Dina

http://www.w3.org/2001/XMLSchema#string

Catherine M T Sherwin

http://www.w3.org/2001/XMLSchema#string

Hermine I Brunner

http://www.w3.org/2001/XMLSchema#string

Kristina Wiers

http://www.w3.org/2001/XMLSchema#string

Marisa S Klein-Gitelman

http://www.w3.org/2001/XMLSchema#string

Shannen Nelson

http://www.w3.org/2001/XMLSchema#string

Shareen Cox

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Fukuda

http://www.w3.org/2001/XMLSchema#string

P2860

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.

Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil.

Mycophenolate mofetil and its mechanisms of action.

Mechanism of action of mycophenolate mofetil.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.

Therapeutic monitoring of mycophenolate mofetil.

Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?

The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease

P304

307-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SEMARTHRIT.2010.05.007

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45286514

http://www.w3.org/2001/XMLSchema#string

P698

20655577

http://www.w3.org/2001/XMLSchema#string

P932

3021770

http://www.w3.org/2001/XMLSchema#string